Abstract
Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 496-501 |
| Number of pages | 6 |
| Journal | Cardiovascular and Interventional Radiology |
| Volume | 40 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2017 |
Bibliographical note
Publisher Copyright:© 2016, Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Colon cancer
- Drug elutting beads
- Transarterial chemoembolization (TACE)
Fingerprint
Dive into the research topics of 'Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS